Opko Health Inc. (OPK) Short Interest Update
Opko Health Inc. (NASDAQ:OPK) was the target of a large drop in short interest during the month of January. As of January 31st, there was short interest totalling 54,047,933 shares, a drop of 4.1% from the January 12th total of 56,361,612 shares. Based on an average trading volume of 5,905,560 shares, the days-to-cover ratio is presently 9.2 days. Currently, 16.4% of the company’s shares are sold short.
Several research firms recently issued reports on OPK. Zacks Investment Research upgraded Opko Health from a “sell” rating to a “hold” rating in a research report on Thursday, October 26th. Cantor Fitzgerald set a $20.00 price objective on Opko Health and gave the stock a “buy” rating in a report on Wednesday, October 25th. Finally, BidaskClub cut Opko Health from a “hold” rating to a “sell” rating in a report on Saturday, November 11th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and five have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $13.34.
Shares of Opko Health (NASDAQ:OPK) opened at $3.95 on Tuesday. Opko Health has a fifty-two week low of $3.61 and a fifty-two week high of $8.92. The company has a debt-to-equity ratio of 0.01, a current ratio of 1.66 and a quick ratio of 1.48. The firm has a market capitalization of $2,210.00, a P/E ratio of -20.79 and a beta of 1.42.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in OPK. Crossmark Global Holdings Inc. purchased a new stake in Opko Health in the 3rd quarter worth approximately $118,000. State of Alaska Department of Revenue purchased a new stake in Opko Health in the 4th quarter worth approximately $144,000. The Manufacturers Life Insurance Company lifted its holdings in Opko Health by 7.9% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 22,535 shares of the biotechnology company’s stock worth $149,000 after buying an additional 1,657 shares during the period. Psagot Investment House Ltd. lifted its holdings in Opko Health by 20.0% in the 2nd quarter. Psagot Investment House Ltd. now owns 22,862 shares of the biotechnology company’s stock worth $150,000 after buying an additional 3,806 shares during the period. Finally, First Trust Advisors LP purchased a new stake in Opko Health in the 4th quarter worth approximately $154,000. Institutional investors and hedge funds own 22.68% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: This article was reported by Daily Political and is owned by of Daily Political. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this article can be accessed at https://www.dailypolitical.com/2018/02/12/opko-health-inc-opk-short-interest-update.html.
Opko Health Company Profile
OPKO Health, Inc is a healthcare company. Its segments include Pharmaceutical, Diagnostics and Corporate. Pharmaceutical consists of the pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain and its pharmaceutical research and development operations. Diagnostics consists of the clinical laboratory operations in Bio-Reference Laboratories (Bio-Reference) and its point-of-care operations.
Receive News & Ratings for Opko Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opko Health and related companies with MarketBeat.com's FREE daily email newsletter.